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XPF-ERCC1 and XPG proteins are nucleases that are
involved in human nucleotide excision repair. In this
study, we characterized the structure-specific junction-
cutting activities of both nucleases using DNA sub-
strates containing a bubble or loop structure. We found
that the junction-cutting activities of XPF-ERCC1 and
XPG were greatly stimulated by human replication pro-
tein A (RPA), while heterologous single-stranded DNA-
binding proteins could not substitute for human RPA.
To test for specific interaction between RPA and XPF-
ERCC1 as is known to occur between RPA and XPG, we
employed a pull-down assay with immobilized “bubble”
substrate. We found that the binding of XPF-ERCC1
complex to the bubble substrate was enhanced by RPA,
suggesting a possiblemechanism for RPA in the excision
nuclease system, that is the targeting of the nuclease
subunits to their specific sites of action. Furthermore,
the RPA-promoted junction cutting by XPF-ERCC1 and
XPG nucleases was observed with “loop” substrates as
well, raising the possibility that XPF-ERCC1, XPG, and
RPA may function in removing loop structures from
DNA, independent of the other subunits of the human
excinuclease.
Nucleotide excision repair is a general repair system that
plays an important role in maintaining genetic integrity (1, 2).
This repair system removes damaged nucleotides from DNA by
dual incisions on both sides of the lesion in the damaged strand
(3). Recently, the human and the highly homologous yeast
nucleotide excision repair systems have been reconstituted
from extensively purified proteins, which demonstrated that
14–15 polypeptides comprising replication protein A (RPA,1
also known as HSSB or RF-A) and the general transcription
factor, TFIIH, in addition to XP and ERCC proteins were
essential for the dual incision step (4–6).
It was found that the two subunits of the excision nuclease
had intrinsic endonuclease activities in the absence of the other
components of the repair system. XPG was reported to possess
a single-stranded DNA endonuclease activity (7, 8) and an
exonuclease activity with 59 to 39 directionality (9). Similarly, it
was found that XPF-ERCC1 had a single strand-specific endo-
nuclease activity and a weak activity on double-stranded UV-
irradiated DNA, which was stimulated by RPA (10). Further-
more, it has been reported that the RAD1-RAD10 complex (11),
the yeast counterpart of the human XPF-ERCC1 nuclease, and
XPG nuclease (12) have structure-specific junction-cutting ac-
tivities with unique polarities. These results obtained with the
model “undamaged” substrates suggested that XPF-ERCC1
and XPG were the 59- and 39-endonucleases of the dual inci-
sions, respectively. A recent study using damaged DNA and
specific antibodies supported this model (13).
Recently, it has been reported that RPA, which is absolutely
required for dual incisions (4), specifically binds to XPA protein
and XPG nuclease (14). These findings raised the possibility
that RPA may play an important role in recognizing DNA
lesions and then targeting the nuclease subunits of human
excision nuclease system to their proper sites. Hence, we de-
cided to investigate the effect of RPA on the nuclease subunits
in the absence of other components of excision nuclease.
EXPERIMENTAL PROCEDURES
DNA Substrates—Structures of DNA substrates used in this study
were schematically drawn in Fig. 1a. The sequence of the top strand of
each substrate was identical: 59-CCTGCCTAGGATCCAGTAGTCG-
ACTTGGACGAACCCGGGATGGAATGGAGTATTCGCCGTGTCCATG-
GCTGTAAGTATCCAGGATCCCGG-39. This top strand oligomer (90-
mer) was 59- or 39-labeled with T4 polynucleotide kinase and [g-32P]ATP
or terminal deoxynucleotidyltransferase and [a-32P]dideoxy-ATP, re-
spectively, and gel-purified. Hence, the size of the 39-labeled top strand
was 91-mer. After annealing with respective bottom strand oligomers,
double-stranded DNAs with or without a bubble/loop structure were
purified using non-denaturing 8% polyacrylamide gels. The sequences
of bottom strands were: DS, 59-CCGGGATCCTGGATACTTACAGCC-
ATGGACACGGCGAATACTCCATTCCATCCCGGGTTCGTCCAAGTC-





AGGCAGG-39 (90-mer); L12, 59-CCGGGATCCTGGATACTTACAGC-
CATGGACACGGCGAATCCCGGGTTCGTCCAAGTCGACTACTGGA-
TCCTAGGCAGG-39 (78-mer); L30, 59CCGGGATCCTGGATACTTAC-
AGCCATGTTCGTCCAAGTCGACTACTGGATCCTAGGCAGG-39 (60-
mer). Mismatched bases in the bubble substrates are underlined. Five
femtomoles of the labeled substrates per nuclease reaction were used in
all experiments in this study.
Proteins—The XPA cDNA tagged with 6 3 histidine using pRSET
vector (Invitrogen) was overexpressed in Escherichia coli DR153 strain
(15) and purified by a modified procedure of Jones and Wood (16). The
DNA construct bearing the three-subunit human RPA was obtained
from Dr. M. Wold (University of Iowa), and the recombinant RPA was
expressed in E. coli and purified according to Henricksen et al. (17).
Purification of XPF-ERCC1 complex was carried out as described pre-
viously (10). Protein concentrations were ;4 ng/ml (the heparin-agarose
column fraction), ;10 ng/ml (the DEAE-column fraction), and 33 ng/ml
(the XPA-affinity column fraction).
XPG protein was overexpressed in a baculovirus/insect cell system
using pVL1392-XPG/Baculogold viral DNA (Pharmingen) and SF21
cells and extensively purified by a modified procedure of O’Donovan et
al. (7). Briefly, after separation on a phosphocellulose column, XPG-
containing fractions identified by Western blotting were loaded onto an
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Affi-Gel blue (Bio-Rad) column. The column was extensively washed
with buffer A (25 mM HEPES-KOH, pH 7.9, 1 mM EDTA, 1 mM dithi-
othreitol, and 10% glycerol) containing 150 mM KCl and subsequently
with buffer A containing 1 M KCl. Final elution was achieved with a
linear gradient of NaSCN (0.5–1.5 M) in buffer A. XPG fractions were
dialyzed against storage buffer (25 mM HEPES-KOH, pH 7.9, 100 mM
KCl, 12 mM MgCl2, 0.5 mM EDTA, 2 mM dithiothreitol, and 17% glyc-
erol) and used in most of the experiments. For further purification, the
elution fractions from the Affi-Gel blue column were dialyzed against
buffer A containing 1 M (NH4)2SO4 and loaded onto a phenyl-Superose
column (HR 5/5, Pharmacia Biotech Inc.). After extensive washing,
XPG was eluted with a linear gradient of (NH4)2SO4 (0.6–0 M) in buffer
A and dialyzed against storage buffer. The purified XPG protein was
active for complementing repair deficiency of UV135 (ERCC-5 5 XP-G)
cell-free extract in an excision assay (3, 13) (data not shown).
Endonuclease Assay—59-Labeled or 39-labeled substrates were incu-
bated at 37 °C for 90 min with XPF-ERCC1 or XPG in 7.5 ml of nuclease
reaction buffer (25 mM HEPES-KOH, pH 7.9, 25 mM KCl, 3 mM MgCl2,
1 mM dithiothreitol, 100 mg/ml bovine serum albumin, and 6.5% glyc-
erol). The products were analyzed on denaturing 10% polyacrylamide
gels, and the level of incision was quantified by PhosphorImager (Mo-
lecular Dynamics).
Pull-down Assay Using Immobilized DNA—The top strand oligomer
of the substrates shown in Fig. 1a was 39-labeled with biotin-16-
dideoxy-UTP using terminal deoxynucleotidyltransferase according to
the manufacturer’s protocol (Boehringer Mannheim). DS and B30 sub-
strates were prepared as described above. Five mg of Dynabeads M-280
streptavidin (Dynal) was incubated at 30 °C for 1 h with the biotin-
labeled DS or B30 substrates (400 ng) in nuclease reaction buffer and
washed with the same buffer three times using a magnetic particle
concentrator (Dynal). Immobilized substrate DNAs were incubated at
4 °C for 3 h with rocking, with RPA, XPA, XPF-ERCC1 (the XPA-
affinity column fraction that contained 330 ng/ml protein), or a combi-
nation of these proteins as indicated, in 50 ml of nuclease reaction buffer
containing 3 mM CaCl2, in place of MgCl2, to inhibit the nuclease
activity of XPF-ERCC1 (10) and 1% bovine serum albumin to reduce
nonspecific binding of proteins to the magnetic beads. The purified
beads were mixed with SDS-loading buffer and heated. The bound
fractions were separated on a 10% polyacrylamide SDS gel, and West-
ern blotting was carried out using standard procedure.
RESULTS AND DISCUSSION
To study the effect of RPA on XPF-ERCC1 and XPG, we
constructed substrates with 12- or 30-nt mismatched bases
(bubble), or deleted nucleotides in the bottom strand (loop) (Fig.
1a). The substrates were labeled 59 or 39 and characterized with
respect to single-strandedness by S1 nuclease digestion. From
the specific degradation by S1 nuclease, it is evident that the
substrates used in our study contained no secondary structures
in the bubble and loop regions (Fig. 1b). RPA, which has high
affinity for single-stranded DNA, specifically bound to the
30-nt bubble or loop region (Fig. 1c) and protected it from
DNase I (Fig. 1d); it also bound to the 12-nt bubble and loop
with less affinity (data not shown), in agreement with the
report that a 30-nt-long single-stranded DNA is the minimum
size for binding of RPA with high affinity (18).
XPF-ERCC1 is a single strand-specific endonuclease, which
also nicks UV-irradiated supercoiled DNA in an RPA-stimu-
lated reaction (10). Furthermore, it was found that the XPF-
ERCC1 complex purified through the XPA-affinity column step
contained a junction-cutting activity, which was not obvious in
the purer fractions (the DEAE and the heparin-agarose frac-
tions) (Fig. 2a). We reasoned that some other protein(s) present
in the XPA-column fraction might have conferred the junction-
cutting activity to XPF-ERCC1 detected with this fraction.
Since RPA binds to these model substrates, we tested RPA for
conferring the junction-cutting activity to the DEAE and the
heparin-agarose fractions (Fig. 2b). In the absence of additional
protein(s), the purer XPF-ERCC1 fractions have a weak single-
stranded nuclease activity, which generates a ladder in the
area of single strandedness (Fig. 2b, lanes 1, 4, and 8). The
addition of RPA suppresses the nonspecific endonuclease activ-
ity while conferring a specific junction-cutting activity upon the
nuclease enabling it to hydrolyze the strand which enters the
bubble region in the 59 to 39 direction at the fourth phosphodi-
ester bond before entering the junction (Fig. 2b, lanes 2, 3, 6,
and 9). RPA also stimulated the junction-cutting activity of the
XPA-column fraction (see below). In contrast, XPA, which is
known to interact with XPF-ERCC1 (19), does not affect the
single-stranded DNA endonuclease activity (Fig. 2b, lanes 5
and 10) and has no significant effect on the RPA-conferred
junction-cutting activity of XPF-ERCC1 (Fig. 2b, lanes 7 and
11). Importantly, RPA failed to confer a junction-cutting activ-
ity to the S1 nuclease (Fig. 2c), indicating that the RPA-pro-
moted junction-cutting activity is not caused by covering the
bubble with RPA and leaving only the single-stranded junction
region open for a nonspecific single-stranded DNA endonucle-
ase. The junction-cutting activity of XPF-ERCC1 was depend-
ent on RPA concentration, and 40 ng of RPA per reaction
FIG. 1. RPA specifically binds to the bubble or loop region in
DNA. a, structures of bubble and loop substrates used in this study.
The top strand was 59- or 39-labeled, and the size of the 39-labeled top
strand, indicated in parentheses, was 1 nucleotide longer than that of
the 59-labeled top strand, as described under “Experimental Proce-
dures.” b, S1 nuclease digestion of the substrate DNAs. 59-Labeled
substrates were incubated at 20 °C for 20 min with 0.5 unit of S1
nuclease (Life Technologies, Inc.) in 30 mM sodium acetate (pH 4.6), 1
mM zinc acetate, 50 mM NaCl, and 5% glycerol, and the products were
analyzed on a denaturing 10% polyacrylamide gel. M, size markers
(fX174/HinfI); lane 1, DS; lane 2, B12; lane 3, B30; lane 4, L12; lane 5,
L30. c, specific binding of RPA to substrate DNAs containing a bubble
or loop structure (gel shift assay). DS (lanes 1–5), B30 (lanes 6–10), or
L30 (lanes 11–15) substrates were incubated at 30 °C for 15 min with
the indicated amounts of human RPA in nuclease reaction buffer. The
samples were directly loaded onto a non-denaturing 4% polyacrylamide
gel in 1 3 TBE (90 mM Tris borate, pH 8.5, 2 mM EDTA). d, specific
binding of RPA to the bubble or loop region in substrate DNAs (DNase
I footprinting). 59-Labeled B30 (B30–59, lanes 1–5) or L30 (L30–59,
lanes 6–10) substrates were preincubated on ice for 30 min with the
indicated amounts of RPA in nuclease reaction buffer. DNase I (0.02
unit, Life Technologies, Inc.) was added, and the reaction was carried
out at 20 °C for 10 min. The products were separated on denaturing
10% polyacrylamide gels. M, size markers (fX174/HinfI).
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stimulated the activity about 64-fold (Fig. 2d). We wished to
know the DNA structure requirements for the RPA-stimulated
junction-cutting activity. As shown in Fig. 2e, the junction-
cutting activity of the XPA-column fraction is greatly stimu-
lated by RPA, and a smaller (12-nt) bubble structure is incised
in the same way as the 30-nt bubble although with lower
efficiency (lanes 1–3 compared with lanes 4–6). Interestingly,
similar results were obtained with loop structures. Both the 12-
and 30-nt loop substrates were incised in a manner similar to
the bubble substrates (lanes 7–12).
Similar experiments were conducted with XPG nuclease,
which is known to have a junction-cutting activity in a bubble
substrate (12) and to interact with RPA (14). Fig. 3a shows the
effects of RPA on the XPG junction-cutting activity with the
30-nt bubble and loop substrates. Under our experimental con-
ditions, a very weak junction-cutting activity of XPG was ob-
served with both substrates (;1% incision) (Fig. 3a, lanes 1 and
7), which is specific for the junction with entering the bubble/
loop region in 39 to 59 direction. Addition of RPA stimulated the
junction-cutting activity in a concentration-dependent manner
(Fig. 3a, lanes 2–6 and 8–11), although the optimal RPA con-
centration and the major incision sites were different between
the two substrates. The junction-cutting activity stimulated by
RPA can be inhibited by anti-XPG antibodies (Fig. 3b). We
failed to detect a significant XPG junction-cutting activity with
smaller (12-nt) bubble and loop substrates under these condi-
tions (data not shown).
These results, taken together, support a model of excision
nuclease reaction where RPA may stabilize the unwound DNA
region (presumably caused by TFIIH helicase activity) and
recruit the two nucleases, XPF-ERCC1 and XPG, to their
proper sites through physical interactions as is known to occur
FIG. 2. Stimulation of junction-cutting activities of XPF-
ERCC1 by RPA. a, nuclease activities of various XPF-ERCC1 chro-
matographic fractions on the bubble substrate. 59-Labeled B30 sub-
strate was incubated at 37 °C for 90 min with 2 ml of buffer only (lane
1), the XPA-affinity column fraction (lane 2), the DEAE-column fraction
(lane 3), or the heparin-agarose column fraction (lane 4). b, effects of
RPA and XPA on a junction-cutting activity of XPF-ERCC1. 59-Labeled
(lanes 1–7) or 39-labeled (lanes 8–11) B30 substrates were preincubated
on ice for 10 min with no protein (lanes 1, 4, and 8), 10 ng of RPA (lanes
3, 6, and 9), 20 ng of RPA (lane 2), 10 ng of XPA (lanes 5 and 10), or 10
ng of XPA and 10 ng of RPA (lanes 7 and 11) prior to the incubation with
1 ml of the heparin-agarose column fraction (lanes 1–3) or the DEAE-
column fraction (lanes 4–11) of XPF-ERCC1. In addition to the products
caused by the XPF-ERCC1 junction-cutting activity, smaller fragments
were reproducibly obtained with 59-labeled substrates (lanes 2, 3, 6, and
7). These fragments might be by-products of XPF-ERCC1 junction cut-
ting followed by 39 3 59 exonucleolytic degradation. However, it is not
clear whether this exonuclease activity is intrinsic to XPF-ERCC1.
Minor effects of XPA on the RPA-promoted junction-cutting activity
(lanes 7 and 11) are due to experimental variability, because it has not
been reproduced in repeated experiments. c, effects of RPA on the S1
nuclease activity. 59-Labeled B30 substrate was preincubated on ice for
30 min with no protein (lane 1), the indicated amounts of RPA (lanes 2
and 3), or E. coli SSB (lanes 4 and 5), followed by the addition of S1
nuclease. d, titration of the RPA-conferred junction-cutting activity.
Top, 39-labeled B30 substrate was preincubated on ice for 10 min with
the indicated amounts of RPA (lanes 1–5) or E. coli SSB (lane 6) prior to
the incubation with 1 ml of the DEAE-column fraction of XPF-ERCC1.
Bottom, quantitative analysis of the data shown in the top panel. e,
DNA structure requirements for the RPA-conferred junction-cutting
activity. 39-Labeled B12 (lanes 1–3), B30 (lanes 4–6), L12 (lanes 7–9), or
L30 (lanes 10–12) substrates were preincubated on ice for 10 min with
the indicated amounts of RPA, followed by the addition of 1 ml of the
XPA-affinity column fraction of XPF-ERCC1. M, size markers
(fX174/HinfI).
FIG. 3. Stimulation of junction-cutting activities of XPG by
RPA. a, effects of RPA on junction-cutting activity of XPG. Top, 59-
labeled B30 (lanes 1–6) or L30 (lanes 7–12) substrates were preincu-
bated on ice for 10 min with the indicated amounts of RPA (lanes 1–11)
or E. coli SSB (lane 12) prior to the incubation with XPG (;10 ng).
Bottom, quantitative analysis of the data shown in the top panel. b,
inhibition of the junction-cutting activity by anti-XPG antibodies. 39-
Labeled L30 substrate was incubated on ice for 10 min with no RPA
(lane 1) or 10 ng of RPA (lanes 2–4). XPG protein (;10 ng) preincubated
with no antibody (lanes 1 and 2), buffer only (lane 3), or affinity-purified
anti-XPG antibodies (13) (lane 4) was added to the reaction mixture and
incubated at 37 °C for 90 min.M, size markers (fX174/HinfI). Note that
the apparent higher level of XPG-directed cutting with L30–39 than
with L30–59 is due to the higher specific radioactivity of the L30–39
substrate.
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between RPA and XPG (14). In fact, consistent with this model,
neither E. coli single-stranded DNA-binding protein (SSB)
(Fig. 2d, lane 6 and Fig. 3a, lane 12) nor yeast RPA (data not
shown) could stimulate the junction-cutting activities of the
two human nucleases, and human RPA did not stimulate non-
specific endonuclease activities of XPG and XPF-ERCC1 on
single-stranded DNA substrate (data not shown). However,
direct interaction between RPA and XPF-ERCC1 has not been
reported so far, despite the known interactions of XPA with
RPA (14, 20, 21) and ERCC1 (19, 22, 23).
In light of our results, which demonstrate stimulation of
XPF-ERCC1 by RPA in the absence of XPA, we conducted a
pull-down assay to test whether XPF-ERCC1 binding to the
bubble substrate can be enhanced in the presence of RPA
without the mediation of XPA (Fig. 4). The immobilized 30-nt
bubble substrate was incubated with RPA, XPA, XPF-ERCC1,
or a combination of these proteins. RPA bound to this substrate
specifically and efficiently (lanes 5–8 compared with lanes 10
and 11), while XPF-ERCC1 bound to the bubble substrate
weakly in the absence of RPA (lane 4). When XPF-ERCC1 was
incubated with the substrate in the presence of RPA, more
XPF-ERCC1 bound to the bubble substrate (lanes 5 and 6). In
contrast, XPA did not affect the XPF-ERCC1 binding to this
substrate (lane 7). Yeast RPA failed to facilitate XPF-ERCC1
binding to the bubble substrate (data not shown), consistent
with the failure of yeast RPA to confer a junction-cutting ac-
tivity to XPF-ERCC1. These results suggest that human RPA
recruits XPF-ERCC1 onto the bubble substrate DNA, possibly
either through direct interaction or by creating a unique DNA
structure.
One reasonable question is why does the XPA-column frac-
tion have a junction-cutting activity but the purer fractions do
not? The contamination of RPA in the XPA-column fraction
seems to be unlikely, because no trace of RPA (or XPA) could be
detected by either silver staining or Western blotting with high
sensitivity (data not shown, also see Fig. 4). A simple explana-
tion is that XPF-ERCC1 has an intrinsic junction-cutting ac-
tivity without RPA, which becomes nonspecific at low concen-
trations of the enzyme. Indeed, the diluted XPA-column
fraction showed a nonspecific single-stranded DNA endonucle-
ase activity (data not shown) rather than a junction-cutting
activity (which could be restored by adding RPA).
Our results show that RPA plays an essential role in posi-
tioning the two nuclease subunits of the human excision nu-
clease system. Furthermore, these results show that, with loop
structures of 12–30 nt in length, RPA, XPG, and XPF-ERCC1
are capable of removing the loop by incising the strand with
extra nucleotides on both sides of the loops. The human MutLS
system is capable of eliminating mismatches and loops up to 4
nucleotides (24). However, it was reported that loops of 5, 8,
and 16 nucleotides can be removed in a hMLH1-independent
manner (25). Moreover, it has been found that the yeast Schiz-
osaccharomyces pombe exonuclease I (26) and the Saccharomy-
ces cerevisiae RTH1 nuclease (27), which belong to the extended
family of XPG/RAD2/Rad13 and FEN-1/Rad2 proteins, play
roles in mismatch corrections. Thus, it is possible that XPG and
XPF-ERCC1 proteins, in addition to their roles in damage
excision repair, may participate in removing the looped-out
DNAwith a relatively large size and hence in genomic stability.
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FIG. 4. Enhanced binding of XPF-ERCC1 to the bubble sub-
strate in the presence of RPA. Lanes 1–3 contain RPA (0.2 mg), XPA
(0.1 mg), and XPF-ERCC1 (1 ml), respectively. Immobilized B30 sub-
strate was incubated with the indicated amounts of XPF-ERCC1 (lane
4), XPF-ERCC1 and RPA (lanes 5 and 6), XPF-ERCC1, RPA, and XPA
(lane 7), RPA and XPA (lane 8), or XPA (lane 9). Immobilized DS
substrate was incubated with 0.2 mg (lane 10) or 1.0 mg (lane 11) of RPA.
The bound fractions were analyzed by Western blotting using a mixture
of anti-p34 (RPA) (Oncogene Science), anti-XPA, and anti-ERCC1 (13)
antibodies.
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